Jacobio Pharmaceuticals Reveals Board Composition
Company Announcements

Jacobio Pharmaceuticals Reveals Board Composition

Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167) has released an update.

Jacobio Pharmaceuticals Group Co., Ltd. has announced its board of directors, listing both executive and non-executive members, including the composition of its three main committees – Audit, Remuneration, and Nomination. The announcement details the leadership within each committee, with Dr. Yinxiang Wang, Dr. Ruilin Song, and Dr. Bai Lu chairing the respective committees and multiple members serving across different ones. This organizational update comes as a significant insight for investors monitoring corporate governance and leadership efficacy.

For further insights into HK:1167 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App